Literature DB >> 30714122

Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Romain Barus1, Johana Béné1, Julie Deguil1, Sophie Gautier1, Régis Bordet1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30714122      PMCID： PMC6715604          DOI： 10.1111/bph.14607

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  150 in total

1.  Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat.

Authors:  Guobin Bao; Lin Kang; Haohong Li; Yuting Li; Lu Pu; Peng Xia; Lan Ma; Gang Pei
Journal:  Neuropsychopharmacology       Date:  2007-01-24       Impact factor: 7.853

2.  Use of statins and risk of hospitalization with dementia: a Danish population-based case-control study.

Authors:  Henriette Thisted Horsdal; Anne Vingård Olesen; Christiane Gasse; Henrik Toft Sørensen; Robert C Green; Søren Paaske Johnsen
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jan-Mar       Impact factor: 2.703

3.  Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers.

Authors:  S N Ramage; I C Anthony; F W Carnie; A Busuttil; R Robertson; J E Bell
Journal:  Neuropathol Appl Neurobiol       Date:  2005-08       Impact factor: 8.090

Review 4.  Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism.

Authors:  Alvin V Terry; Sahebarao P Mahadik
Journal:  J Pharmacol Exp Ther       Date:  2006-09-11       Impact factor: 4.030

5.  The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women.

Authors:  S Yasar; J Zhou; R Varadhan; M C Carlson
Journal:  Clin Pharmacol Ther       Date:  2008-03-19       Impact factor: 6.875

6.  Cognitive impairment in cancer pain patients receiving opioids: a pilot study.

Authors:  Geana Paula Kurita; Cibele Andrucioli de Mattos Pimenta
Journal:  Cancer Nurs       Date:  2008 Jan-Feb       Impact factor: 2.592

7.  Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

Authors:  Michael Davidson; Silvana Galderisi; Mark Weiser; Nomi Werbeloff; Wolfgang W Fleischhacker; Richard S Keefe; Han Boter; Ireneus P M Keet; Dan Prelipceanu; Janusz K Rybakowski; Jan Libiger; Martina Hummer; Sonia Dollfus; Juan J López-Ibor; Luchezar G Hranov; Wolfgang Gaebel; Joseph Peuskens; Nils Lindefors; Anita Riecher-Rössler; René S Kahn
Journal:  Am J Psychiatry       Date:  2009-04-15       Impact factor: 18.112

8.  The use of central nervous system drugs and analgesics among very old people with and without dementia.

Authors:  Hugo Lövheim; Stig Karlsson; Yngve Gustafson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

9.  Psychotropic medication use and cognition in institutionalized older adults with mild to moderate dementia.

Authors:  Laura H P Eggermont; Kerst de Vries; Erik J A Scherder
Journal:  Int Psychogeriatr       Date:  2009-02-26       Impact factor: 3.878

10.  A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

Authors:  Clive Ballard; Marisa Margallo Lana; Megan Theodoulou; Simon Douglas; Rupert McShane; Robin Jacoby; Katja Kossakowski; Ly-Mee Yu; Edmund Juszczak
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069
View more
  2 in total

1.  Therapeutics for dementia and Alzheimer's disease: New directions for precision medicine.

Authors:  J A Duce; X Zhu; L H Jacobson; P M Beart
Journal:  Br J Pharmacol       Date:  2019-09       Impact factor: 8.739

2.  Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews.

Authors:  Patrícia Ferreira; Ana Rita Ferreira; Beatriz Barreto; Lia Fernandes
Journal:  Eur Geriatr Med       Date:  2021-08-17       Impact factor: 1.710
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.